[go: up one dir, main page]

GB2432211B - Agglutination based assay system - Google Patents

Agglutination based assay system

Info

Publication number
GB2432211B
GB2432211B GB0523124A GB0523124A GB2432211B GB 2432211 B GB2432211 B GB 2432211B GB 0523124 A GB0523124 A GB 0523124A GB 0523124 A GB0523124 A GB 0523124A GB 2432211 B GB2432211 B GB 2432211B
Authority
GB
United Kingdom
Prior art keywords
assay system
based assay
agglutination based
agglutination
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0523124A
Other versions
GB0523124D0 (en
GB2432211A (en
Inventor
Carolyn Jennifer Ruddell
Gerald John Allen
Douglas Robert Evans
Elizabeth Garner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Platform Diagnostics Ltd
Original Assignee
Platform Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Platform Diagnostics Ltd filed Critical Platform Diagnostics Ltd
Priority to GB0523124A priority Critical patent/GB2432211B/en
Publication of GB0523124D0 publication Critical patent/GB0523124D0/en
Priority to CN200680042072.6A priority patent/CN101305282B/en
Priority to EP06808497A priority patent/EP1952158A2/en
Priority to EP13172799.2A priority patent/EP2674757A3/en
Priority to CN2012105747290A priority patent/CN103091487A/en
Priority to PCT/GB2006/004204 priority patent/WO2007054714A2/en
Priority to JP2008539499A priority patent/JP5426881B2/en
Priority to CA2629290A priority patent/CA2629290C/en
Priority to AU2006313611A priority patent/AU2006313611B2/en
Priority to US12/093,440 priority patent/US9201065B2/en
Publication of GB2432211A publication Critical patent/GB2432211A/en
Application granted granted Critical
Publication of GB2432211B publication Critical patent/GB2432211B/en
Priority to JP2013097647A priority patent/JP2013174612A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552—Glass or silica
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
GB0523124A 2005-11-12 2005-11-12 Agglutination based assay system Expired - Fee Related GB2432211B (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB0523124A GB2432211B (en) 2005-11-12 2005-11-12 Agglutination based assay system
JP2008539499A JP5426881B2 (en) 2005-11-12 2006-11-13 Aggregation assay
AU2006313611A AU2006313611B2 (en) 2005-11-12 2006-11-13 Agglutination assay
EP13172799.2A EP2674757A3 (en) 2005-11-12 2006-11-13 Agglutination assay
CN2012105747290A CN103091487A (en) 2005-11-12 2006-11-13 Agglutination assay
PCT/GB2006/004204 WO2007054714A2 (en) 2005-11-12 2006-11-13 Agglutination assay
CN200680042072.6A CN101305282B (en) 2005-11-12 2006-11-13 Agglutination assay
CA2629290A CA2629290C (en) 2005-11-12 2006-11-13 Agglutination assay
EP06808497A EP1952158A2 (en) 2005-11-12 2006-11-13 Agglutination assay
US12/093,440 US9201065B2 (en) 2005-11-12 2006-11-13 Agglutination assay
JP2013097647A JP2013174612A (en) 2005-11-12 2013-05-07 Agglutination assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0523124A GB2432211B (en) 2005-11-12 2005-11-12 Agglutination based assay system

Publications (3)

Publication Number Publication Date
GB0523124D0 GB0523124D0 (en) 2005-12-21
GB2432211A GB2432211A (en) 2007-05-16
GB2432211B true GB2432211B (en) 2009-04-22

Family

ID=35516844

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0523124A Expired - Fee Related GB2432211B (en) 2005-11-12 2005-11-12 Agglutination based assay system

Country Status (2)

Country Link
CN (1) CN101305282B (en)
GB (1) GB2432211B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010101703A (en) * 2008-10-22 2010-05-06 Alfresa Pharma Corp Immunoassay and measuring reagent kit
GB201017447D0 (en) 2010-10-15 2010-12-01 Moorlodge Biotech Ventures Ltd Assay device
CN103163304A (en) * 2011-12-19 2013-06-19 天津中新科炬生物制药有限公司 Method for rapidly detecting follicle stimulating hormone (FSH) in urine sample in a quantitative mode
CN102749445A (en) * 2012-06-29 2012-10-24 中国人民解放军军事医学科学院军事兽医研究所 Method for improving rabies neutralizing antibody detection sensitivity in latex agglutination test
CN111812336A (en) * 2020-08-10 2020-10-23 苏州康和顺医疗技术有限公司 Detection kit for detecting coronavirus antibodies and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004492A1 (en) * 1989-09-25 1991-04-04 Agen Limited Agglutination assay
US5413913A (en) * 1987-09-07 1995-05-09 Agen Biomedical, Ltd. Erythrocyte agglutination assay
EP0818680A1 (en) * 1996-07-12 1998-01-14 Daiichi Pure Chemicals Co. Ltd. Agglutination immunoassay
US6136545A (en) * 1996-09-13 2000-10-24 Roche Diagnostics Gmbh Homogeneous detection methods for the determination of subpopulations of an analyte
US20050069967A1 (en) * 2003-09-30 2005-03-31 Wako Pure Chemical Industries, Ltd. Reagent for an immunoassay

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2045431B (en) * 1979-02-26 1983-04-20 Technicon Instr Immunoassay utilising two particulate reagents
JPS63305251A (en) * 1987-06-05 1988-12-13 Dai Ichi Pure Chem Co Ltd Immunological measurement method using latex agglutination reaction
JPH04350559A (en) * 1991-05-28 1992-12-04 Dai Ichi Pure Chem Co Ltd Measuring method for specific antibody
US20040106157A1 (en) * 2000-12-11 2004-06-03 Kunihiko Nakahara Immunological assay reagents and assay method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413913A (en) * 1987-09-07 1995-05-09 Agen Biomedical, Ltd. Erythrocyte agglutination assay
WO1991004492A1 (en) * 1989-09-25 1991-04-04 Agen Limited Agglutination assay
EP0818680A1 (en) * 1996-07-12 1998-01-14 Daiichi Pure Chemicals Co. Ltd. Agglutination immunoassay
US6136545A (en) * 1996-09-13 2000-10-24 Roche Diagnostics Gmbh Homogeneous detection methods for the determination of subpopulations of an analyte
US20050069967A1 (en) * 2003-09-30 2005-03-31 Wako Pure Chemical Industries, Ltd. Reagent for an immunoassay

Also Published As

Publication number Publication date
GB0523124D0 (en) 2005-12-21
GB2432211A (en) 2007-05-16
CN101305282A (en) 2008-11-12
CN101305282B (en) 2013-04-03

Similar Documents

Publication Publication Date Title
IL187106A (en) Sclerostin-binding antibody
IL190472A0 (en) Anti-glypican-3 antibody
IL192266A0 (en) Anti-ilt7 antibody
IL185366A0 (en) Antibody
IL186425A0 (en) Stilbazium research assays
GB0409771D0 (en) Assay
IL187521A0 (en) Assay device
GB2430032B (en) Assay Device
GB0606822D0 (en) Assay System
EP1845838A4 (en) Knowledge determination system
EP1869219A4 (en) Multiplex assay systems
GB2432211B (en) Agglutination based assay system
EP1842183A4 (en) Complete orchestration system
GB0519605D0 (en) Assay
GB0407526D0 (en) Assay
GB0408853D0 (en) Assay
GB0511279D0 (en) Assay
GB0502065D0 (en) Assay method
EP1971202A4 (en) Serum production system
GB0503741D0 (en) Assay
GB0522579D0 (en) Assay system
GB0622475D0 (en) Assay system
GB0610973D0 (en) Agglutination assay
GB0511893D0 (en) Assay method
GB0424533D0 (en) Assay system

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20171112